{"id":"W2036488279","doi":"10.1016/j.jaad.2004.09.029","title":"Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":213,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Randomized controlled trial; Dermatology; Plaque psoriasis; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002555184,0.00193025,0.004639807,0.0003852794,0.0006061026,0.001321084,0.001068957,0.001777647,0.005966607],"category_scores_gemma":[0.00194935,0.0006992132,0.002754985,0.0006000915,0.001387176,0.001584408,0.0004892775,0.003867331,0.0009304668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008432841,"about_ca_system_score_gemma":0.0007956814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001062189,"about_ca_topic_score_gemma":0.002034208,"domain_scores_codex":[0.9990993,0.0004041174,0.00005293741,0.0001630327,0.00007377328,0.0002069994],"domain_scores_gemma":[0.99858,0.0004328959,0.000290724,0.0001967591,0.0000837917,0.000415844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9739397,0.003243187,0.0007411203,0.0005220197,0.002635806,0.00004771209,0.00004657654,0.0003196801,0.001780212,0.00007378273,0.000769218,0.01588098],"study_design_scores_gemma":[0.9729519,0.02177006,0.00326107,0.00003445102,0.0009904917,0.00004140463,0.00001888644,0.000141904,0.0001733305,0.0001205319,0.0004825079,0.00001346575],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794258,0.01271994,0.0008606408,0.00116178,0.0004966132,0.001481858,0.001446006,0.0001409175,0.002266503],"genre_scores_gemma":[0.9842011,0.00566027,0.001688099,0.001734735,0.000535003,0.001822623,0.001881765,0.00003475319,0.002441571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005966607,"threshold_uncertainty_score":0.01996028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01780253160628653,"score_gpt":0.298222103744109,"score_spread":0.2804195721378224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}